8.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
watching and looking
mega
re: CHMR 1.94 monster
be safe
link thru
re: CHMR 1.87 x 1.88
be safe
link thru
re: CHMR 1.73's
from 1.05
link thru
GROV looks great this morn
re: CHMR 1.57 x 1.58 now
from 1.05
link thru
yes indeed~
you can say that again
EPAZ .0375 pm well dang..lol
and then right back to .018 x .019 wacky
unreal grinder
BMPI beast
today's promoted stocks
HotStockProfits.com BTHR Yes 8/9/2012 $3,000.00 Reg FD Error Details
FreeInsiderAlerts.com DIGX Yes 8/9/2012 $20,000.00 Creme Consulting Group, LLC Details
Pennystockpaycheck.com EPAZ Yes 8/9/2012 $10,000.00 EAG Details
EmailStockPicks.com EPAZ Yes 8/9/2012 $10,000.00 Equities Awareness Group Details
BlaqueCapitalStocks.com EPAZ Yes 8/9/2012 $10,000.00 Equities Awareness Group Details
Pennystockguru.net FMBV Yes 8/9/2012 $85,000.00 Wall Street Relations Details
pennystocksvip.com FMBV Yes 8/9/2012 $85,000.00 Wall Street Relations Details
StockLegends.com GROV Yes 8/9/2012 $5,000.00 Raincity Marketing Group Details
atomicpennies.com IMDC Yes 8/9/2012 $7,500.00 Reg FD Error Details
MajorPennyStocks.com INOL Yes 8/9/2012 $5,000.00 Novel Exploration Details
Smallcapvoice.com JAMN Yes 8/9/2012 $1,750.00 Company Details
StockRunway.com LDSI Yes 8/9/2012 $5,000.00 Tumaco Ventures, Inc. Details
MonsterPennyPick.com LDSI Yes 8/9/2012 $10,000.00 Micro-Cap Innovations Details
PennyStockHeroes.com MDMC Yes 8/9/2012 $500,000.00 Reg FD Error Details
Selectpennystocks.com MDMC Yes 8/9/2012 $500,000.00 Reg FD Error Details
preferredpennystocks.com MDMC Yes 8/9/2012 $500,000.00 Reg FD Error Details
GrowingStocksReport.com WRAP Yes 8/9/2012 $30,000.00 BCC, Inc. Details
Researchdrivenalerts.com WRAP Yes 8/9/2012 $30,000.00 BCC, Inc. Details
Researchdriveninvestor.com WRAP Yes 8/9/2012 $30,000.00 BCC, Inc. Details
PennyStockScholar.com WRAP Yes 8/9/2012 $12,500.00 RDI, LLC Details
Equitytradingalert.com WRAP Yes 8/9/2012 $12,500.00 RDI, LLC Details
OTCTipreporter.com WRAP Yes 8/9/2012 $12,500.00 RDI, LLC Details
MicroCapProfiler.com WRAP Yes 8/9/2012 $12,500.00 RDI, LLC
morning my friend ~ you as well~
re: CTSO news 8.9.12 CytoSorbents to Present and Exhibit at the Military Health System Research Symposium
MONMOUTH JUNCTION, NJ -- (Marketwire) -- 08/09/12 -- CytoSorbents Corporation (OTCBB: CTSO), a critical care focused company using blood purification to modulate the immune system, reduce severe inflammation, and prevent or treat organ failure caused by life-threatening illnesses, announced that it has been selected to give a 20 minute presentation on CytoSorb® at the Military Health System Research Symposium. The meeting will be held at the Harbor Beach Marriott Hotel in Fort Lauderdale, Florida, from August 13-16, 2012. Dr. Phillip Chan, Chief Executive Officer, will present preclinical and clinical data on CytoSorb® on Tuesday, August 14, 2012 at 1:20PM in the Organ Dysfunction and Failure breakout session. CytoSorbents will also be showcasing its blood purification technologies, including CytoSorb® and HemoDefend, during the conference in Booth #70.
MHSRS is the tri-service symposium that now incorporates the ATACCC, AFMRS, and Navy Medicine Research Conference. The conference is the premier scientific meeting to address the unique medical needs of the warfighter and a collaborative environment for military medical care providers with deployment experience, Department of Defense (DoD) scientists, academia, and industry who will discuss and address the advancement of research and health care development in areas of Combat Casualty Care, Military Operational Medicine, Clinical and Rehabilitative Medicine, and Military Infectious Disease Research Programs. (https://www.ataccc.org)
Dr. Chan stated, "With Phase I SBIR funding from the United States Army Medical Research and Materiel Command to develop our technologies for the treatment of trauma, as well as our recent DARPA contract announcement to develop next generation cytokine and toxin adsorbing sorbents to treat sepsis, we are pleased to have the opportunity to address a broader group of military healthcare leaders from the United States and our European Allies. We hope through broader exposure, we will gain greater funding support for our unique blood purification technologies."
The Phase I SBIR grant was supported by the US Army Medical Research and Materiel Command under Contract No W81XWH-12-C-0038.
The DARPA contract is based upon work supported by DARPA and SSC Pacific under Contract No. N66001-12-C-4199. Any opinions, findings and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of DARPA and SSC Pacific.
About CytoSorbents, CytoSorb®, and HemoDefend
CytoSorbents Corporation is a critical care focused therapeutic device company using blood purification to modulate the immune system and fight multi-organ failure in life-threatening illnesses. Its purification technology is based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and adsorption. In 2011, CytoSorb®, the Company's flagship product, achieved European regulatory approval as an extracorporeal cytokine filter, and can now be sold throughout the European Union (E.U.) under the CE Mark to be used in clinical situations where cytokines are elevated. The goal of CytoSorb® is to modulate the immune system by reducing "cytokine storm" in critically-ill patients that could otherwise lead to deadly inflammation, multiple organ failure, immune dysfunction, and often death in common illnesses such as sepsis, trauma, burn injury, acute respiratory distress syndrome, and pancreatitis. CytoSorb® has demonstrated statistically significant reductions in mortality in septic patients at high risk of death in early studies and is now being sold in Germany for the treatment of critical care illnesses, with availability in other E.U. countries planned in the future, assuming adequate and timely funding, and continued positive results from our clinical studies. HemoDefend is a development-stage blood purification technology platform for the blood transfusion industry intended to reduce transfusion reactions and safeguard the quality and safety of blood products. The HemoDefend technology utilizes the Company's polymer bead technology to remove many substances, such as antibodies, free hemoglobin and inflammatory mediators that can cause potentially serious and sometimes fatal transfusion reactions. CytoSorb® and HemoDefend are just two of a number of different polymers the Company has designed for various medical applications, including improved dialysis, reduction of post-surgical complications, the potential treatment of inflammatory and autoimmune disorders, rhabdomyolysis in trauma, drug detoxification, and others. Additional information is available for download on the Company's website: www.cytosorbents.com
Forward-Looking Statements
This press release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release are not promises or guarantees and are subject to risks and uncertainties that could cause our actual results to differ materially from those anticipated. These statements are based on management's current expectations and assumptions and are naturally subject to uncertainty and changes in circumstances. We caution you not to place undue reliance upon any such forward-looking statements. Actual results may differ materially from those expressed or implied by the statements herein. CytoSorbents Corporation and CytoSorbents, Inc believe that its primary risk factors include, but are not limited to: obtaining government approvals including required FDA and additional CE Mark approvals; ability to successfully develop commercial operations; dependence on key personnel; acceptance of the Company's medical devices in the marketplace; the outcome of pending and potential litigation; compliance with governmental regulations; reliance on research and testing facilities of various universities and institutions; the ability to obtain adequate and timely financing in the future when needed; product liability risks; limited manufacturing experience; limited marketing, sales and distribution experience; market acceptance of the Company's products; competition; unexpected changes in technologies and technological advances; and other factors detailed in the Company's Form 10-K filed with the SEC on March 30, 2012, which is available at http://www.sec.gov.
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=1985309
Contact:
CytoSorbents Corporation
Dr. Phillip Chan
Chief Executive Officer
(732) 329-8885 ext. *823
pchan@cytosorbents.com
Source: Marketwire (August 9, 2012 - 6:50 AM EDT)
News by QuoteMedia
www.quotemedia.com
Another one of those days ~ heading out ~ enjoy all and good luck
Indeed ~ goes like that sometimes.
Nice trade though ~ good job.
morning bud~
public and you can see the incredible volume they are bringing...not
lol.
Stockmister never starts runs - only finishes.
kiss o' death...lol
morning my friend
Stockmister out on ESPI
I think you are correct.
nice job ~ followed you
juice is fairly minimal normally, and that recent DIDG payday was an anomaly.
here's their last few comps...
Stockbrainiac.com UBRG Yes 6/25/2012 $40,000.00
StockBrainiac.com CFGX Yes 6/28/2012 $9,000.00
StockBrainiac.com CFGX Yes 6/29/2012 $9,000.00
StockBrainiac.com KALO Yes 7/9/2012 $25,000.00
StockBrainiac.com DIDG Yes 7/31/2012 $664,970.00
yessir ~ that should be your money, but x 20
lol...
these silly guys ~
http://stockbrainiac.com/
they just got $675k comp for DIDG of recent.
didn't see EPAZ comp yet
*edit ~ just $17.5k comp
StockBrainiac going out on EPAZ
no doubt about it.
what an cannibalistic weird industry...lol
good times.
whoa. I guess those posts went through...lol
somebody help me out...
crazy ihub... :)
you just might have something there bud.
we shall see~
The TBX email has the APS wording also!
Our next pick is: Coming Soon!
Hi Everyone,
Following a reorg and under new Management, we Finally have a "firm" date for the announcement of the next pick.
Please make sure to add us to your 'safe-sender'(contact) list to ensure that the newsletter goes to your inbox as we will be releasing the newest pick by next week.
Tell your friends who are not signed up to go ahead and sign up right now. You can forward this email to your contact list to facilitate the process.
Fund your brokerage account now so that you can buy the new pick as soon as it's announced!
It seems like an eternity since we last announced a money-maker for you guys but rest assured that the time is finally near.
Get ready to trade! August is going to be an awesome month.
Happy Trading!
Your TBX Editor
http://bullexchange.com
Twitter: https://twitter.com/#!/TheBullExchange
unreal and well, here we go
The TBX email has the APS wording also!
Our next pick is: Coming Soon!
Hi Everyone,
Following a reorg and under new Management, we Finally have a "firm" date for the announcement of the next pick.
Please make sure to add us to your 'safe-sender'(contact) list to ensure that the newsletter goes to your inbox as we will be releasing the newest pick by next week.
Tell your friends who are not signed up to go ahead and sign up right now. You can forward this email to your contact list to facilitate the process.
Fund your brokerage account now so that you can buy the new pick as soon as it's announced!
It seems like an eternity since we last announced a money-maker for you guys but rest assured that the time is finally near.
Get ready to trade! August is going to be an awesome month.
Happy Trading!
Your TBX Editor
http://bullexchange.com
Twitter: https://twitter.com/#!/TheBullExchange
TBX pleased to announce our Next pick by next week! Get ready to trade as we expect an "awesome" month of August.
well, well...lol
https://twitter.com/TheBullExchange
Some list stealing and suit filing ~ I highly doubt they would collab...
I suppose you never know ~ money is crazy.
But, i doubt it.
Indeed. Hmmmmmmm :)
New TBX pick "by next week"
Maybe, but pour me a glass while you're at it
No doubt...lol :/